Shareholders May Be A Bit More Conservative With Hygeia Healthcare Holdings Co., Limited's (HKG:6078) CEO Compensation For Now

Advertisement

Key Insights

The underwhelming share price performance of Hygeia Healthcare Holdings Co., Limited (HKG:6078) in the past three years would have disappointed many shareholders. However, what is unusual is that EPS growth has been positive, suggesting that the share price has diverged from fundamentals. The AGM coming up on the 28th of June could be an opportunity for shareholders to bring these concerns to the board's attention. They could also try to influence management and firm direction through voting on resolutions such as executive remuneration and other company matters. We discuss below why we think shareholders should be cautious of approving a raise for the CEO at the moment.

See our latest analysis for Hygeia Healthcare Holdings

Comparing Hygeia Healthcare Holdings Co., Limited's CEO Compensation With The Industry

According to our data, Hygeia Healthcare Holdings Co., Limited has a market capitalization of HK$18b, and paid its CEO total annual compensation worth CN¥2.5m over the year to December 2023. Notably, that's a decrease of 33% over the year before. While this analysis focuses on total compensation, it's worth acknowledging that the salary portion is lower, valued at CN¥600k.

On comparing similar companies from the Hong Kong Healthcare industry with market caps ranging from HK$7.8b to HK$25b, we found that the median CEO total compensation was CN¥2.6m. From this we gather that Yiwen Zhu is paid around the median for CEOs in the industry. What's more, Yiwen Zhu holds HK$8.2b worth of shares in the company in their own name, indicating that they have a lot of skin in the game.

Component20232022Proportion (2023)
SalaryCN¥600kCN¥492k24%
OtherCN¥1.9mCN¥3.2m76%
Total CompensationCN¥2.5m CN¥3.7m100%

On an industry level, around 72% of total compensation represents salary and 28% is other remuneration. In Hygeia Healthcare Holdings' case, non-salary compensation represents a greater slice of total remuneration, in comparison to the broader industry. If non-salary compensation dominates total pay, it's an indicator that the executive's salary is tied to company performance.

ceo-compensation
SEHK:6078 CEO Compensation June 21st 2024

Hygeia Healthcare Holdings Co., Limited's Growth

Hygeia Healthcare Holdings Co., Limited's earnings per share (EPS) grew 42% per year over the last three years. In the last year, its revenue is up 28%.

This demonstrates that the company has been improving recently and is good news for the shareholders. Most shareholders would be pleased to see strong revenue growth combined with EPS growth. This combo suggests a fast growing business. Looking ahead, you might want to check this free visual report on analyst forecasts for the company's future earnings..

Has Hygeia Healthcare Holdings Co., Limited Been A Good Investment?

The return of -71% over three years would not have pleased Hygeia Healthcare Holdings Co., Limited shareholders. This suggests it would be unwise for the company to pay the CEO too generously.

To Conclude...

The fact that shareholders are sitting on a loss on the value of their shares in the past few years is certainly disconcerting. A huge lag in share price growth when earnings have grown may indicate there could be other issues that are affecting the company at the moment that the market is focused on. Shareholders would probably be keen to find out what are the other factors could be weighing down the stock. The upcoming AGM will be a chance for shareholders to question the board on key matters, such as CEO remuneration or any other issues they might have and revisit their investment thesis with regards to the company.

If you think CEO compensation levels are interesting you will probably really like this free visualization of insider trading at Hygeia Healthcare Holdings.

Of course, you might find a fantastic investment by looking at a different set of stocks. So take a peek at this free list of interesting companies.

Valuation is complex, but we're here to simplify it.

Discover if Hygeia Healthcare Holdings might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About SEHK:6078

Hygeia Healthcare Holdings

Offers oncology healthcare services in the People's Republic of China.

Adequate balance sheet with moderate growth potential.

Advertisement

Weekly Picks

LO
Lou_Basenese
GANX logo
Lou_Basenese on Gain Therapeutics ·

The Market Is Sleeping on This Parkinson's Biotech - And I Think That's a Mistake

Fair Value:US$7.675.1% undervalued
16 users have followed this narrative
0 users have commented on this narrative
16 users have liked this narrative
KI
NVDA logo
Kingman1152 on NVIDIA ·

NVIDIA will see a profit margin surge of 55% in the next 5 years

Fair Value:US$305.235.6% undervalued
42 users have followed this narrative
1 users have commented on this narrative
16 users have liked this narrative
TE
BUSER logo
TechMegaTrends on Bambuser ·

Bambuser is today the only listed company in Europe that simultaneously possesses an 85% gross margin, proprietary AI infrastructure for the

Fair Value:SEK 238.2685.8% undervalued
29 users have followed this narrative
0 users have commented on this narrative
13 users have liked this narrative
HE
HedgeY
CSTM logo
HedgeY on Constellium ·

Constellium jet another cyclical aluminum processor, or a mispriced aluminum platform?

Fair Value:US$3412.8% undervalued
4 users have followed this narrative
0 users have commented on this narrative
2 users have liked this narrative

Updated Narratives

AV
TGAMES logo
avt on TROPHY GAMES Development ·

TROPHY GAMES Development Will See Revenue Rise by 22% in the Next 3 Years

Fair Value:DKK 21.0133.6% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
KI
NVDA logo
Kingman1152 on NVIDIA ·

NVIDIA will see a profit margin surge of 55% in the next 5 years

Fair Value:US$305.235.6% undervalued
42 users have followed this narrative
1 users have commented on this narrative
0 users have liked this narrative
RE
VLTA logo
REElax on Volta Metals ·

Springer REE deposit valuation

Fair Value:CA$3.594.1% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

TR
tripledub
MSFT logo
tripledub on Microsoft ·

Everyone's Terrified Microsoft Will Keep Spending. I'm Terrified They'll Stop.

Fair Value:US$3950.5% undervalued
45 users have followed this narrative
3 users have commented on this narrative
42 users have liked this narrative
RO
Robbo
TSLA logo
Robbo on Tesla ·

The academically fascinating Tesla

Fair Value:US$301.2k% overvalued
38 users have followed this narrative
11 users have commented on this narrative
32 users have liked this narrative
AN
AnalystConsensusTarget
MSFT logo
AnalystConsensusTarget on Microsoft ·

Analyst Commentary Highlights Microsoft AI Momentum and Upward Valuation Amid Growth and Competitive Risks

Fair Value:US$587.3133.1% undervalued
1362 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative